+44 7893 947543
Mon - Fri 09:00 - 17:00
As Ramadan approaches, many patients taking GLP-1 receptor agonist therapy with medications such as Mounjaro (tirzepatide) and Wegovy (semaglutide) may have questions about managing their treatment during fasting hours. These medications offer our patients at Dr.Online a great resource to aid weight loss alongside lifestyle changes. Fasting during Ramadan requires thoughtful adjustments to ensure blood sugar stability and overall health.
Mounjaro and Wegovy are long-acting GLP-1 receptor agonists administered as once-weekly injections. They improve blood sugar control, reduce appetite, and promote weight loss, making them ideal for individuals living with obesity.
Given their once-weekly dosing schedules, they are generally more convenient during Ramadan, as they don’t require daily adjustments. However, the unique dietary changes during fasting necessitate some key considerations.
1. Timing of Administration
2. Dosage Adjustments
3. Monitoring for Side Effects
4. Preventing Hypoglycemia (low blood sugars)
5. Dietary Considerations
6. Hydration
While fasting is a religious obligation, Islam allows exceptions for those who are ill or whose health might be compromised.
Before Ramadan begins, schedule a consultation with your healthcare provider to review your treatment plan. This is especially important if you’re new to Mounjaro or Wegovy or have recently adjusted your dose.
Fasting during Ramadan while taking Mounjaro or Wegovy is possible with proper planning and monitoring. Stick to your prescribed treatment, maintain a balanced diet, and stay hydrated during non-fasting hours. Most importantly, listen to your body and consult your healthcare provider if you have any concerns.
Wishing you a healthy, safe, and blessed Ramadan.
Dr. Winiger, Medical Director at Dr.Online
References – https://pmc.ncbi.nlm.nih.gov/articles/PMC10761230/
https://pmc.ncbi.nlm.nih.gov/articles/PMC9672258/
